Generated SecPen_NY-ESO-1_ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses

Dendritic cell-based cancer vaccines (DC vaccines) have been proved efficient and safe in immunotherapy of various cancers, including melanoma, ovarian and prostate cancer. However, the clinical responses were not always satisfied. Here we proposed a novel strategy to prepare DC vaccines. In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yunkai, Guo, Xiaohan, Hu, Bo, He, Peng, Jiang, Xiaowu, Wang, Zuohuan, Zhu, Huaxing, Hu, Lina, Yu, Minghua, Feng, Meiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893120/
https://www.ncbi.nlm.nih.gov/pubmed/33643825
http://dx.doi.org/10.1016/j.apsb.2020.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893120/
https://www.ncbi.nlm.nih.gov/pubmed/33643825
http://dx.doi.org/10.1016/j.apsb.2020.08.004

Ejemplares similares